… In our previous general review on the pharmacology and therapeutics of bronchodilators, …
in the arterial blood (PaO 2 ) despite concomitant bronchodilation [6]. Dose-related tremor is …

… bronchodilators are the mainstay of therapy due to their proven efficacy. GOLD guidelines
recommend combining long-acting bronchodilators … As such, careful consideration of the most …

… of these LABA/LAMA combinations is beyond the scope of this review, although consideration
will be given to safety data pertaining to the newer LAMA monocomponents within these …

… directly induce bronchodilation by … therapy should be recommended for patients with COPD
who are not fully controlled with one long-acting bronchodilator to maximize bronchodilation. …

… are major targets for bronchodilator therapy. Bronchodilation can be achieved through 2 … ,
there are pharmacokinetic drug interaction considerations with some β agonists. Salmeterol is …

… These two assessments can help guide the initiation of bronchodilator therapy and other
management decisions in stable patients with COPD. In Table 2 , we score a hypothetical …

… of bronchodilators used for asthma and COPD. This study will focus on the use of bronchodilator
… ) in elderly concerning therapeutic targets to be achieved and adverse effects. Use of …

… on the pharmacokinetics of bronchodilators, especially when … the pharmacokinetics of
bronchodilators, although a modest … a systemic safety profile of inhaled bronchodilators but not …

… bronchodilator that is routinely used for COPD, and is less commonly used as first-line therapy
… However, ipratropium is often prescribed in combination with albuterol for the treatment of …

… of bronchodilator and in identifying novel classes of bronchodilator drugs. However, new
classes of … This review discusses recent advancements in knowledge on bronchodilators and …